"Hodgkin Disease" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen.
Descriptor ID |
D006689
|
MeSH Number(s) |
C04.557.386.355 C15.604.515.569.355 C20.683.515.761.355
|
Concept/Terms |
Hodgkin Disease- Hodgkin Disease
- Disease, Hodgkin
- Granuloma, Hodgkin's
- Hodgkin's Granuloma
- Granuloma, Hodgkins
- Hodgkins Granuloma
- Lymphogranuloma, Malignant
- Lymphogranulomas, Malignant
- Malignant Lymphogranuloma
- Malignant Lymphogranulomas
- Hodgkin Lymphoma
- Lymphoma, Hodgkin
- Hodgkin's Disease
- Disease, Hodgkin's
- Hodgkin's Lymphoma
- Hodgkins Lymphoma
- Lymphoma, Hodgkin's
- Hodgkins Disease
- Disease, Hodgkins
- Granuloma, Hodgkin
- Hodgkin Granuloma
- Granuloma, Malignant
- Malignant Granuloma
- Malignant Granulomas
|
Below are MeSH descriptors whose meaning is more general than "Hodgkin Disease".
Below are MeSH descriptors whose meaning is more specific than "Hodgkin Disease".
This graph shows the total number of publications written about "Hodgkin Disease" by people in this website by year, and whether "Hodgkin Disease" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 9 | 1 | 10 |
1995 | 8 | 1 | 9 |
1996 | 9 | 1 | 10 |
1997 | 14 | 2 | 16 |
1998 | 11 | 2 | 13 |
1999 | 5 | 2 | 7 |
2000 | 6 | 3 | 9 |
2001 | 6 | 1 | 7 |
2002 | 11 | 2 | 13 |
2003 | 18 | 1 | 19 |
2004 | 15 | 2 | 17 |
2005 | 10 | 4 | 14 |
2006 | 23 | 3 | 26 |
2007 | 15 | 0 | 15 |
2008 | 16 | 5 | 21 |
2009 | 10 | 2 | 12 |
2010 | 11 | 3 | 14 |
2011 | 19 | 0 | 19 |
2012 | 18 | 3 | 21 |
2013 | 18 | 1 | 19 |
2014 | 17 | 1 | 18 |
2015 | 20 | 3 | 23 |
2016 | 30 | 2 | 32 |
2017 | 24 | 3 | 27 |
2018 | 27 | 2 | 29 |
2019 | 13 | 4 | 17 |
2020 | 23 | 0 | 23 |
2021 | 21 | 2 | 23 |
2022 | 19 | 0 | 19 |
2023 | 18 | 0 | 18 |
2024 | 5 | 0 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hodgkin Disease" by people in Profiles.
-
Brentuximab vedotin with chemotherapy in adolescents and young adults with stage III or IV classical Hodgkin lymphoma in ECHELON-1. Haematologica. 2024 Mar 01; 109(3):982-987.
-
Patient preferences in the treatment of stage III/IV classic Hodgkin lymphoma: Results from the CONNECT cross-sectional survey. Br J Haematol. 2024 Apr; 204(4):1262-1270.
-
Adolescent and young adult Hodgkin lymphoma patients at risk for subcutaneous fat gain during early cancer treatment: a brief report. Leuk Lymphoma. 2024 Jan; 65(1):62-68.
-
Barriers to long-term follow-up in pediatric Hodgkin lymphoma survivors. Pediatr Blood Cancer. 2024 Apr; 71(4):e30855.
-
Late Cardiac Toxic Effects Associated With Treatment Protocols for Hodgkin Lymphoma in Children. JAMA Netw Open. 2024 Jan 02; 7(1):e2351062.
-
Impact of cumulative dose of brentuximab vedotin on outcomes of frontline therapy for advanced-stage Hodgkin lymphoma. Blood Adv. 2023 12 26; 7(24):7485-7493.
-
Role of non-chromosomal birth defects on the risk of developing childhood Hodgkin lymphoma: A Children's Oncology Group study. Pediatr Blood Cancer. 2024 Mar; 71(3):e30822.
-
Management of limited-stage Hodgkin lymphoma. Hematology Am Soc Hematol Educ Program. 2023 Dec 08; 2023(1):500-509.
-
The impact of classic Hodgkin lymphoma on informal caregivers: results from the CONNECT cross-sectional survey. Support Care Cancer. 2023 Nov 02; 31(12):664.
-
Early skeletal muscle loss in adolescent and young adult cancer patients treated with anthracycline chemotherapy. Cancer Med. 2023 11; 12(22):20798-20809.